Company Filing History:
Years Active: 2020-2024
Title: The Innovations of Daniël Verhoef
Introduction
Daniël Verhoef is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical science, particularly in the development of prohemostatic proteins. With a total of 4 patents, his work focuses on advancing treatments for bleeding disorders.
Latest Patents
Verhoef's latest patents include innovative recombinant FXa polypeptides designed to serve as antidotes. These polypeptides can completely or partially reverse the anti-coagulant effects of coagulation inhibitors, especially direct factor Xa inhibitors. His disclosures detail methods for utilizing recombinant factor Xa proteins to effectively manage bleeding in patients.
Career Highlights
Daniël Verhoef is affiliated with Academisch Ziekenhuis Leiden, where he conducts his research and development. His work has been instrumental in enhancing therapeutic options for patients suffering from bleeding complications. His expertise in the field has positioned him as a key figure in medical innovation.
Collaborations
Some of his notable coworkers include Pieter Hendrik Reitsma and Mettine H A Bos. Their collaborative efforts contribute to the advancement of research in coagulation and hemostasis.
Conclusion
Daniël Verhoef's contributions to medical science through his patents and research are invaluable. His work continues to pave the way for new treatments that can significantly improve patient outcomes.